Investigator
IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University
Milano, Lombardia, Italy
Disclosure(s): Bristol-Myers Squibb: Advisor/Consultant; Gilead Sciences, Inc.: Advisor/Consultant, Grant/Research Support, Honoraria; Janssen: Advisor/Consultant, Grant/Research Support, Honoraria; Merck Sharp & Dohme: Advisor/Consultant, Grant/Research Support, Honoraria; ViiV Healthcare: Advisor/Consultant, Grant/Research Support, Honoraria
92 - Obeldesivir Reduced SARS-CoV-2 Infectious Titers in the BIRCH Phase 3 Clinical Trial
Thursday, October 17, 2024
11:30 AM – 11:43 AM US PT